Clinical Trials Directory

Trials / Completed

CompletedNCT04836221

Comorbidities And Reducing inEquitieS

Multi-level Interventions to Manage Co-morbidities Among Black Breast and Prostate Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Medstar Health Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Black cancer patients tend to have worse outcomes than White cancer patients. Some of this disparity may be due to comorbidities. The purpose of this study is to improve management of co-morbidities among cancer patients in order to improve cancer outcomes and improve health equity. Comorbidities such as diabetes and hypertension can complicate cancer treatment or can make it difficult to reach optimal health after treatment. This study will offer additional support and tools to manage cancer patient's health needs. First, the study will use a mobile health application, managed by a company called Welldoc, to monitor patient progress in real time and to provide ongoing guidance. Second, the study will connect patients with a Community Health Worker who will speak with them weekly to discuss self-care information, including medical scheduling or appointment needs, and assist with daily self-monitoring of blood pressure and/or blood glucose monitoring. Lastly, an oncology nurse will monitor reported health and triage any medical needs and whether additional medical care is needed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSupportCommunity Health Workers will conduct weekly phone calls to monitor blood pressure or blood glucose, to check in on patient need for social, practical or emotional supports, and to encourage healthy lifestyle modification. Participants will also have access to a mobile app to support chronic disease management (Either diabetes or hypertension).

Timeline

Start date
2021-05-05
Primary completion
2023-06-10
Completion
2023-06-10
First posted
2021-04-08
Last updated
2023-06-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04836221. Inclusion in this directory is not an endorsement.